
Insiders Updates
Goldman analysts initates a Neutral rating for NewAmsterdam Pharma Company NV (NAMS)
NewAmsterdam Pharma Company NV’s recent filing unveils that its Chief Operating Officer Kling Douglas F unloaded Company’s shares for reported